annual EBITDA:
-$113.16M+$364.71M(+76.32%)Summary
- As of today (June 29, 2025), LEGN annual EBITDA is -$113.16 million, with the most recent change of +$364.71 million (+76.32%) on December 31, 2024.
- During the last 3 years, LEGN annual EBITDA has risen by +$279.22 million (+71.16%).
- LEGN annual EBITDA is now -76045.64% below its all-time high of $149.00 thousand, reached on December 31, 2018.
Performance
LEGN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$88.87M-$141.33M(-269.41%)Summary
- As of today (June 29, 2025), LEGN quarterly EBITDA is -$88.87 million, with the most recent change of -$141.33 million (-269.41%) on March 31, 2025.
- Over the past year, LEGN quarterly EBITDA has dropped by -$40.28 million (-82.89%).
- LEGN quarterly EBITDA is now -269.41% below its all-time high of $52.46 million, reached on December 31, 2024.
Performance
LEGN quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$153.44M-$40.28M(-35.60%)Summary
- As of today (June 29, 2025), LEGN TTM EBITDA is -$153.44 million, with the most recent change of -$40.28 million (-35.60%) on March 31, 2025.
- Over the past year, LEGN TTM EBITDA has increased by +$271.35 million (+63.88%).
- LEGN TTM EBITDA is now -1199.00% below its all-time high of -$11.81 million, reached on March 31, 2019.
Performance
LEGN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
LEGN EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +76.3% | -82.9% | +63.9% |
3 y3 years | +71.2% | -185.9% | +54.3% |
5 y5 years | +9.4% | -102.2% | +5.1% |
LEGN EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +76.3% | -269.4% | +53.6% | -35.6% | +69.0% |
5 y | 5-year | at high | +76.3% | -269.4% | +53.6% | -35.6% | +69.0% |
alltime | all time | <-9999.0% | +76.3% | -269.4% | +53.6% | -1199.0% | +69.0% |
LEGN EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$88.87M(-269.4%) | -$153.44M(+35.6%) |
Dec 2024 | -$113.16M(-76.3%) | $52.46M(-147.7%) | -$113.16M(-62.4%) |
Sep 2024 | - | -$109.91M(+1444.3%) | -$301.26M(+24.0%) |
Jun 2024 | - | -$7.12M(-85.4%) | -$243.00M(-42.8%) |
Mar 2024 | - | -$48.59M(-64.2%) | -$424.79M(-11.1%) |
Dec 2023 | -$477.87M(+14.7%) | -$135.64M(+162.6%) | -$477.87M(+2.1%) |
Sep 2023 | - | -$51.65M(-72.7%) | -$467.85M(-5.0%) |
Jun 2023 | - | -$188.91M(+85.8%) | -$492.64M(-0.5%) |
Mar 2023 | - | -$101.68M(-19.1%) | -$495.17M(+16.6%) |
Dec 2022 | -$416.54M(+6.2%) | -$125.61M(+64.3%) | -$424.57M(+5.1%) |
Sep 2022 | - | -$76.45M(-60.1%) | -$403.96M(-10.1%) |
Jun 2022 | - | -$191.43M(+515.9%) | -$449.20M(+33.8%) |
Mar 2022 | - | -$31.08M(-70.4%) | -$335.60M(-15.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$392.38M(+31.6%) | -$105.01M(-13.7%) | -$399.09M(+12.5%) |
Sep 2021 | - | -$121.69M(+56.4%) | -$354.69M(+18.2%) |
Jun 2021 | - | -$77.83M(-17.7%) | -$299.97M(-16.0%) |
Mar 2021 | - | -$94.56M(+56.0%) | -$356.93M(+16.5%) |
Dec 2020 | -$298.16M(+138.7%) | -$60.61M(-9.5%) | -$306.31M(-0.3%) |
Sep 2020 | - | -$66.96M(-50.3%) | -$307.30M(+14.6%) |
Jun 2020 | - | -$134.79M(+206.7%) | -$268.04M(+65.8%) |
Mar 2020 | - | -$43.95M(-28.7%) | -$161.70M(+24.8%) |
Dec 2019 | -$124.89M(<-9900.0%) | -$61.60M(+122.3%) | -$129.57M(+90.6%) |
Sep 2019 | - | -$27.71M(-2.6%) | -$67.97M(+68.8%) |
Jun 2019 | - | -$28.45M(+140.8%) | -$40.26M(+240.8%) |
Mar 2019 | - | -$11.81M | -$11.81M |
Dec 2018 | $149.00K | - | - |
FAQ
- What is Legend Biotech annual EBITDA?
- What is the all time high annual EBITDA for Legend Biotech?
- What is Legend Biotech annual EBITDA year-on-year change?
- What is Legend Biotech quarterly EBITDA?
- What is the all time high quarterly EBITDA for Legend Biotech?
- What is Legend Biotech quarterly EBITDA year-on-year change?
- What is Legend Biotech TTM EBITDA?
- What is the all time high TTM EBITDA for Legend Biotech?
- What is Legend Biotech TTM EBITDA year-on-year change?
What is Legend Biotech annual EBITDA?
The current annual EBITDA of LEGN is -$113.16M
What is the all time high annual EBITDA for Legend Biotech?
Legend Biotech all-time high annual EBITDA is $149.00K
What is Legend Biotech annual EBITDA year-on-year change?
Over the past year, LEGN annual EBITDA has changed by +$364.71M (+76.32%)
What is Legend Biotech quarterly EBITDA?
The current quarterly EBITDA of LEGN is -$88.87M
What is the all time high quarterly EBITDA for Legend Biotech?
Legend Biotech all-time high quarterly EBITDA is $52.46M
What is Legend Biotech quarterly EBITDA year-on-year change?
Over the past year, LEGN quarterly EBITDA has changed by -$40.28M (-82.89%)
What is Legend Biotech TTM EBITDA?
The current TTM EBITDA of LEGN is -$153.44M
What is the all time high TTM EBITDA for Legend Biotech?
Legend Biotech all-time high TTM EBITDA is -$11.81M
What is Legend Biotech TTM EBITDA year-on-year change?
Over the past year, LEGN TTM EBITDA has changed by +$271.35M (+63.88%)